Analyst consensus rating
ProMIS Neurosciences Analyst Rating: Strong Buy
PMN is rated Strong Buy by 7 analysts with a $43.76 target. As of 2026-08-28.
Direct answer
ProMIS Neurosciences's consensus rating is Strong Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $43.76.
Forecast evidence checked August 28, 2026.
Get free ProMIS Neurosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $13.99
- Average price target
- $43.76
- High price target
- $100.65
- Low price target
- $18.27
- Low target gap
- +30.6%
- Target upside
- +212.8%
- High target gap
- +619.5%
- Target range width
- 588.9%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- August 28, 2026
- Valid through
- September 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for ProMIS Neurosciences?
ProMIS Neurosciences has a verified Strong Buy consensus. The same dataset has an average price target of $43.76.
How far are ProMIS Neurosciences's low and high targets from the recorded price?
The low target implies +30.6%, while the high target implies +619.5%.
How many analysts are included in ProMIS Neurosciences's consensus?
The verified consensus includes 7 analysts.
How is ProMIS Neurosciences's target upside or downside calculated?
The average target of $43.76 is divided by the recorded price of $13.99, then one is subtracted to produce +212.8%. This does not guarantee a future return.
When was ProMIS Neurosciences's analyst forecast verified?
The data was verified on 2026-08-28. The dataset is valid through 2026-09-04.